Audited Results of Natco Pharma Ltd. Company

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Income	4,094.50	3,568.90	2,351	1,767.80	1,653.50
Manufacturing Expenses	93.10	88.90	81.90	76.40	59.40
Personnel Expenses	515.30	454.90	425.70	410.10	380
Selling Expenses	0	0	0	0	0
Administrative Expenses	685.80	756.90	431.60	498.20	268.40
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	1,950.20	1,931.90	1,506.30	1,554.80	1,235.90
Operating Profit	2,144.30	1,637	844.70	213	417.60
Other Recurring Income	321.30	104.70	85.50	94.60	101.10
Adjusted PBDIT	2,465.60	1,741.70	930.20	307.60	518.70
Financial Expenses	19.60	14.50	8.60	13.30	11.30
Depreciation	220	171.90	150.90	138.40	115.20
Other Write offs	0	0	0	0	0
Adjusted PBT	2,226	1,555.30	770.70	155.90	392.20
Tax Charges	375.60	248.70	133.60	16.80	82.70
Adjusted PAT	1,850.40	1,306.60	637.10	139.10	309.50
Non Recurring Items	3	-1.30	1.70	9.80	-0.30
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	1,850.40	1,306.60	637.10	139.10	309.50
Equity Dividend	107.50	170.20	100.40	82.10	113.90
Preference Dividend	0	0	0	0	0
Retained Earnings	5,972.20	4,269.70	3,125.50	2,586.80	2,517.80

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article